Table 1. Association of lncRNA HULC expression with clinicopathologic features in HCC patients.
Parameter | Total | LncRNA HULC | χ2 | P | |
---|---|---|---|---|---|
Low | High | ||||
Age (years) | |||||
<60 | 23 | 10 | 13 | 0.391 | 0.532 |
≥60 | 15 | 5 | 10 | ||
Gender | |||||
Female | 9 | 4 | 5 | - | 1.000 * |
Male | 29 | 11 | 18 | ||
Tumor size (cm) | |||||
<5 | 15 | 5 | 10 | 0.391 | 0.532 |
≥5 | 23 | 10 | 13 | ||
Tumor differentiation | |||||
Well/moderate | 22 | 11 | 11 | 2.423 | 0.120 |
Poor | 16 | 4 | 12 | ||
Clinical stage (TNM) | |||||
I~II | 23 | 12 | 11 | 3.934 | 0.047 |
III~IV | 15 | 3 | 12 | ||
Intrahepatic metastases | |||||
No | 17 | 10 | 7 | 4.821 | 0.028 |
Yes | 21 | 5 | 16 | ||
Distant metastasis | |||||
No | 28 | 14 | 15 | - | 0.061* |
Yes | 10 | 1 | 8 | ||
HCC recurrence | |||||
No | 17 | 10 | 7 | 4.821 | 0.028 |
Yes | 21 | 5 | 16 |
Fisher exact test